These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11086031)

  • 1. Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma.
    Ostrand-Rosenberg S; Grusby MJ; Clements VK
    J Immunol; 2000 Dec; 165(11):6015-9. PubMed ID: 11086031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent.
    Ostrand-Rosenberg S; Clements VK; Terabe M; Park JM; Berzofsky JA; Dissanayake SK
    J Immunol; 2002 Nov; 169(10):5796-804. PubMed ID: 12421960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    J Immunol; 2005 Jan; 174(2):636-45. PubMed ID: 15634881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
    Wang W; Ostlie NS; Conti-Fine BM; Milani M
    J Immunol; 2004 Jan; 172(1):97-103. PubMed ID: 14688314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different competitive capacities of Stat4- and Stat6-deficient CD4+ T cells during lymphophenia-driven proliferation.
    Sanchez-Guajardo V; Borghans JA; Marquez ME; Garcia S; Freitas AA
    J Immunol; 2005 Feb; 174(3):1178-87. PubMed ID: 15661871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi.
    Tarleton RL; Grusby MJ; Zhang L
    J Immunol; 2000 Aug; 165(3):1520-5. PubMed ID: 10903759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells.
    Jensen SM; Meijer SL; Kurt RA; Urba WJ; Hu HM; Fox BA
    J Immunol; 2003 Feb; 170(4):2014-21. PubMed ID: 12574371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The homeostasis but not the differentiation of T cells is regulated by p27(Kip1).
    Shen R; Kaplan MH
    J Immunol; 2002 Jul; 169(2):714-21. PubMed ID: 12097373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.
    Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Paul WE; Sher A
    J Immunol; 2000 Mar; 164(6):3047-55. PubMed ID: 10706693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
    Cretney E; Takeda K; Yagita H; Glaccum M; Peschon JJ; Smyth MJ
    J Immunol; 2002 Feb; 168(3):1356-61. PubMed ID: 11801676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
    Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
    Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal tolerance in the absence of Stat4- and Stat6- dependent Th cell differentiation.
    Chang HC; Zhang S; Kaplan MH
    J Immunol; 2002 Oct; 169(8):4124-8. PubMed ID: 12370340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice.
    Kacha AK; Fallarino F; Markiewicz MA; Gajewski TF
    J Immunol; 2000 Dec; 165(11):6024-8. PubMed ID: 11086033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
    Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
    Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling.
    Nishikomori R; Usui T; Wu CY; Morinobu A; O'Shea JJ; Strober W
    J Immunol; 2002 Oct; 169(8):4388-98. PubMed ID: 12370372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
    Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
    J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.
    Shen XD; Ke B; Zhai Y; Gao F; Anselmo D; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2003 Feb; 37(2):296-303. PubMed ID: 12540779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
    Yu P; Lee Y; Wang Y; Liu X; Auh S; Gajewski TF; Schreiber H; You Z; Kaynor C; Wang X; Fu YX
    J Immunol; 2007 Aug; 179(3):1960-8. PubMed ID: 17641063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.